Nabumetone
- Product NDC
- 52959-650
- 11-digit product format
- 529590650
- Labeler code
- 52959
- Product ID
- 52959-650_0ebcf6fc-a0cf-491d-b833-42ac160dc5e0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nabumetone
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- H.J. Harkins Company, Inc.
- Application
- ANDA078671
- Marketing category
- ANDA
- Marketing start
- 2008-03-01
- Marketing end
- 0000-00-00
- Substance
- NABUMETONE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52959-650-00 | EA - Each | 52959-650 | ad1aaf16-483b-4d68-a578-c26e50a7df7c | 1 | 2012-07-24 |
| 52959-650-14 | EA - Each | 52959-650 | 6ba50f25-04a1-494f-b382-8908be937c09 | 1 | 2012-07-24 |
| 52959-650-20 | EA - Each | 52959-650 | 7ffa2e5f-a39f-4ad1-a429-a870290843f5 | 1 | 2012-07-24 |
| 52959-650-28 | EA - Each | 52959-650 | 965cb82e-7540-410a-b532-5fd6300d2715 | 1 | 2012-07-24 |
| 52959-650-30 | EA - Each | 52959-650 | c09c18c9-e799-4a1e-af35-39c41cd6428a | 1 | 2012-07-24 |
| 52959-650-40 | EA - Each | 52959-650 | bbe5eec0-70d1-42ed-ad0d-647b84a27c57 | 1 | 2012-07-24 |
| 52959-650-42 | EA - Each | 52959-650 | 1bb73732-2c80-4abf-a10d-32a661f0f91b | 1 | 2012-07-24 |
| 52959-650-60 | EA - Each | 52959-650 | dca86bbb-155f-4bc2-bba7-87bee4d6980c | 1 | 2012-07-24 |
| 52959-650-90 | EA - Each | 52959-650 | 91523d6c-2f24-46e4-8716-56678f5764d6 | 1 | 2012-07-24 |